Glossary Updates16 new terms added to the glossaries · November 12, 2026, 21:23 CET
AI TechDocKnowledge

Glossary · EU in vitro diagnostics: IVDR

Performance evaluation (IVDR)

Also known as: Performance evaluation report (PER), IVDR performance evaluation

Under the EU In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746, performance evaluation is the assessment and analysis of data to establish or verify the scientific validity, the analytical performance and, where applicable, the clinical performance of a device. It follows Article 56 and Annex XIII, is documented in a performance evaluation report and is updated throughout the device’s life.

  • EU
  • IVDR
  • Technical documentation

In one sentence

IVDR performance evaluation under Article 56 and Annex XIII: evidence of scientific validity, analytical performance and clinical performance for an IVD.

Example

For a troponin assay, the manufacturer shows scientific validity from published literature on troponin and myocardial infarction, analytical performance from its own precision and detection-limit studies, and clinical performance from a study of sensitivity and specificity in emergency patients.

Explained in context

This term is a station of a mini course

  • The medical-device evidence chain: from intended purpose to post-market evidenceStation: Clinical and performance evidenceStart the course

Context cards connect this term with others to answer one question. Also in British English and German.

How it applies

  • Scientific validity: The association of the analyte with a clinical condition or physiological state, shown from literature, consensus guidelines or studies.
  • Analytical performance: The ability to correctly detect or measure the analyte: for example trueness, precision, analytical sensitivity and specificity, measuring range and interference.
  • Clinical performance: The ability to yield results that correlate with the clinical condition in the target population and intended user: for example diagnostic sensitivity and specificity and predictive values. Where clinical performance data are not required, the manufacturer justifies this.
  • Plan and report: A performance evaluation plan defines the approach and the state of the art benchmarks; the performance evaluation report sets out the evidence and the conclusion on the benefit-risk ratio. MDCG 2022-2 describes the general principles of clinical evidence for IVDs.
  • Updates: Data from PMPF and post-market surveillance update the evaluation. For class C and D devices, the summary of safety and performance (SSP) reflects it.
  • Technical documentation: The performance evaluation report is part of the Annex II technical documentation and shows how the performance-related GSPR are met.

Performance evaluation vs. clinical evaluation

The MDR clinical evaluation asks whether a device is safe and achieves its clinical benefit in or on patients. The IVDR performance evaluation asks whether the test result is scientifically meaningful, analytically correct and clinically accurate; the benefit reaches the patient indirectly, through decisions based on the result. The terms are not interchangeable.

By knowledge.aitechdoc.world · Published September 25, 2026 · Last reviewed

Source: Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR), Article 56 and Annex XIIILaw in force: Binding legislation that applies as of the review date.

Definitions follow the cited standards and specifications. Where a source is a copyrighted publication, such as an ISO, IEC or EN standard, the definition is a close paraphrase, not a verbatim quotation, so as not to infringe copyright. We recommend reading the original publication. The sections “How it applies” are editorial commentary by AI TechDoc Knowledge and are not part of any standard.

Seen a mistake? Send us a note!